How Can Hyper-automated AI Bridge Life Sciences Companies to Complete Digital Transformation?
March 14, 2024 @ 12:00 PM Eastern
Hyper-automated AI has moved beyond futuristic speculation and firmly established itself in the present, revolutionizing industries worldwide and delivering superior efficiencies and insights through a comprehensive suite of machine learning, robotics, natural language query, and other technologies.
Life sciences companies, immersed in the daily data deluge, stand to benefit greatly as well. This technology can significantly enhance existing digital capabilities, transforming complex healthcare data into actionable intelligence in a fraction of the time it would traditionally take. However, while all this certainly sounds very promising (and be that as it may), it is impossible to ignore the necessary changes that organizations will have to undergo before reaching this milestone.
Join industry experts Nuray Yurt (Merck), Ravi Shankar (Novartis), Nadia Tantsyura (Boehringer Ingelheim), Nitin Raizada (Indegene), and Vikas Mahajan (Indegene) as they unpack top use cases and winning execution strategies for Hyper-automated AI in life sciences.
Key questions that will be addressed include:
- Where and how hyper-automated AI can be implemented in life sciences
- Why this technology should be a strategic necessity versus a tactical choice
- How to prepare for such disruptive technology
- Why it’s not a robotic overthrow of humans
- How to deal with interoperability challenges
- Vikas Mahajan, Senior Director of Data and Analytics, Indegene
- Ravi Shankar, Executive Director of Data and Analytics Enablement and Strategic Data Products, Novartis
- Nuray Yurt, Business Engagement and Activation Lead for Digital Data and Analytics, Merck
- Nadia Tantsyura, Global Capability Owner of Data Domain and Analytics, Boehringer Ingelheim
- Nitin Raizada, Vice President of Enterprise Commercial Solutions, Indegene
Mastering Changes in Affiliations & How Your Data Can Keep Up
Presented by Compile
March 20, 2024 @ 12:00 PM Eastern
The current healthcare landscape is incredibly dynamic, with healthcare professionals changing jobs or locations more than ever before. This extensive movement makes it difficult for biopharma teams to pinpoint key decision-makers, identify pertinent organizations for targeted engagement, strategically deploy sales representatives to the right locations, conduct market sizing and forecasting analyses, and much more. Having access to the most up-to-date information on the connections between healthcare professionals and healthcare organizations can make a significant difference in commercial success.
Join us for a deep dive into six months of provider affiliations data to explore how often affiliations change, which specialties move the most, and other factors influencing change. We’ll also delve into what this means for your commercial and data strategy, and discuss techniques to ensure your data can keep up with the current rate of change.
- Ruth Berkowitz, VP Marketing at McKesson Compile
Ruth brings 20+ years of healthcare marketing experience to McKesson Compile. Prior to McKesson Compile, Ruth was Head of Marketing and Co-founder of Centivo, a novel health plan centered around value-based care. Before that, she was Vice President of Product and Marketing for Liazon, operator of the industry-leading benefits exchange, which was acquired by Willis Towers Watson. Previously, Ruth spent over a decade in the pharmaceutical industry leading marketing initiatives in the U.S. and global markets at Pfizer, for high-profile brands including Viagra, Exubera, and Aricept. She began her career in healthcare economic consulting at National Economic Research Associates, where she conducted research on healthcare regulations and pricing.
Ruth holds a BA from Washington University in St. Louis and an MBA from the Kellogg School of Management at Northwestern University. She enjoys blogging, tennis, mah jongg, and educating people at parties about the virtues of pharma.
- Steve Chick, VP Sales at McKesson Compile
Steve Chick leads the sales & account management teams at McKesson Compile.
Steve has served in many roles over his 35+ years in the healthcare services community, including Vice President, Sales & Business Development for Symphony Health, Senior VP, Real World Evidence and Late Phase services for InVentive Health, and Market Vice President at Comprehensive Health Insights. In addition, he led the sales and marketing functions at Evidera and served in various leadership roles at IMS Health.
Steve holds a bachelor’s degree from The Pennsylvania State University. He is a member of the International Society for Pharmacoeconomics and Outcomes Research, and enjoys spending time with his family, exploring the outdoors and playing golf.
- Shivam Soni, Senior Product Manager at McKesson Compile
Shivam is a Senior Product Manager at McKesson Compile, where he leverages his extensive expertise in life sciences analytics and healthcare data. His primary focus lies in enhancing McKesson Compile’s Provider 360 ReadyData offering.
Prior to his role at McKesson Compile, Shivam worked at ZS Associates, where he spearheaded diverse projects ranging from patient journey analytics to competitive tracking, KOL identification, and IDN segmentation.
Shivam holds a Bachelor of Technology degree from VNIT Nagpur, India. Outside of his professional endeavors, he finds joy in exploring new destinations through travel and indulges in a variety of sports including badminton, swimming, chess, and cricket.